Teva reports positive results for fremanezumab in phase IIIb migraine trial

Image: Teva announces positive results for fremanezumab in phase IIIb FOCUS study. Photo: courtesy of Raysonho @ Open Grid Scheduler / Grid Engine / Wikipedia.org.